These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 6788393)
21. hsBAFF enhances activity of NK cells by regulation of CD4(+) T lymphocyte function. Zhang W; Wen L; Huang X; Liang J; Gao W; Zhang S; Chen L Immunol Lett; 2008 Oct; 120(1-2):96-102. PubMed ID: 18687360 [TBL] [Abstract][Full Text] [Related]
22. Heparin enhances generation of natural killer activity in vitro. Wasik M; Górski A Arch Immunol Ther Exp (Warsz); 1994; 42(1):73-6. PubMed ID: 7503640 [TBL] [Abstract][Full Text] [Related]
23. Natural cytotoxic cells against solid tumors in mice: a comparison with natural killer cells. Stutman O; Lattime EC; Figarella EF Fed Proc; 1981 Oct; 40(12):2699-704. PubMed ID: 7286250 [TBL] [Abstract][Full Text] [Related]
24. Level of activation determines whether inflammatory peritoneal and intratumoral macrophages will promote or suppress in vitro development of cytolytic T lymphocyte activity. Gillespie GY; Russell SW J Reticuloendothel Soc; 1980 May; 27(5):535-45. PubMed ID: 7373614 [No Abstract] [Full Text] [Related]
25. [Immunology and tumors. Effector cells]. Sebastiani M; Cosma AM; Ferri AM Arch Sci Med (Torino); 1980; 137(2):277-88. PubMed ID: 6971636 [TBL] [Abstract][Full Text] [Related]
29. Immunomodulating effects of anticancer drugs: the example of adriamycin. Mihich E; Ehrke MJ Transplant Proc; 1984 Apr; 16(2):499-501. PubMed ID: 6609456 [No Abstract] [Full Text] [Related]
30. Cord IgM antibody specific for human killer T cells: T lymphocytotoxic human fetal antibody (TLFA) recognizing maternal killer T cells proliferating in the presence of interleukin 2. Miyagawa Y; Komiyama A; Akabane T; Uehara Y; Yano A J Immunol; 1982 Nov; 129(5):1993-6. PubMed ID: 6981670 [TBL] [Abstract][Full Text] [Related]
31. Enhancement of natural killer cell activity by interferon and interleukin-2 in human large granular lymphocytes inhibited by cyclosporine. Ramsey KM; Dyer D; Stocks N; Djeu JY Transplant Proc; 1984 Dec; 16(6):1628-31. PubMed ID: 6334388 [No Abstract] [Full Text] [Related]
32. Restoration of allogeneic responsiveness of lymphocytes from cyclosporin A-treated animals with interleukin 2. Wang BS; Heacock EH; Zheng CX; Tilney NL; Mannick JA Transplantation; 1982 Apr; 33(4):454-6. PubMed ID: 6978560 [No Abstract] [Full Text] [Related]
33. In vitro and in vivo effects of mercuric chloride on thymic endocrine activity, NK and NKT cell cytotoxicity, cytokine profiles (IL-2, IFN-gamma, IL-6): role of the nitric oxide-L-arginine pathway. Santarelli L; Bracci M; Mocchegiani E Int Immunopharmacol; 2006 Mar; 6(3):376-89. PubMed ID: 16428073 [TBL] [Abstract][Full Text] [Related]
34. Enhanced generation of NK cells with intact cytotoxic function in CD45 exon 6-deficient mice. Yamada H; Kishihara K; Kong YY; Nomoto K J Immunol; 1996 Aug; 157(4):1523-8. PubMed ID: 8759734 [TBL] [Abstract][Full Text] [Related]
35. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells. Son YI; Dallal RM; Mailliard RB; Egawa S; Jonak ZL; Lotze MT Cancer Res; 2001 Feb; 61(3):884-8. PubMed ID: 11221875 [TBL] [Abstract][Full Text] [Related]
36. Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2. Cheever MA; Greenberg PD; Fefer A J Immunol; 1981 Apr; 126(4):1318-22. PubMed ID: 6970768 [No Abstract] [Full Text] [Related]
37. Natural killer (NK) cell activity of women with gross cystic disease is inhibited in vitro by breast cyst fluid. Ardizzoja M; Masera RG; Tacconis P; Sartori ML; Arisio R; Massobrio M; Angeli A Anticancer Res; 1994; 14(2A):555-9. PubMed ID: 8017860 [TBL] [Abstract][Full Text] [Related]
38. Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo. Redlinger RE; Mailliard RB; Lotze MT; Barksdale EM J Pediatr Surg; 2003 Mar; 38(3):301-7; discussion 301-7. PubMed ID: 12632339 [TBL] [Abstract][Full Text] [Related]
39. Natural cell-mediated cytotoxicity against tumors in mice: an heterogeneous system. Stutman O; Lattime EC Transplant Proc; 1981 Mar; 13(1 Pt 2):752-5. PubMed ID: 7268894 [No Abstract] [Full Text] [Related]
40. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells. Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]